Why Aduhelm, a new Alzheimer's treatment, isn't reaching many patients

Why Aduhelm, a new Alzheimer's treatment, isn...

Up next

What's up with recycled wastewater's PR problem?

Would you drink recycled wastewater? It could be a solution to the global water crisis. But not everyone is ready to jump onboard. They say it’s not technology that’s keeping more cities from recycling their wastewater, but psychology. Experts call this resistance “the yuck facto ...  Show more

The world’s freshwater is getting saltier. Why?

Around the world, the planet’s freshwater is getting saltier. And it’s because of people. For decades, salting roads, fertilizer run-off and evaporation driven by human-caused climate change have upped the salinity of lakes, rivers and groundwater. All that salt is detrimental to ...  Show more

Recommended Episodes

Alzheimer's Dementia
Psychiatry & Psychotherapy Podcast

Alzheimer's disease is a devastating neurodegenerative condition that affects the entire family. As psychiatrists and psychologists, we often support these patients and their families throughout this entire disease process. With the recent and controversial FDA approval of aducan ...  Show more

What difference could new Alzheimer’s disease drugs make?
Inside Health

Until recently, breakthroughs in treating Alzheimer’s disease were non-existent. But two new drugs have shown promise in moderately slowing memory and thinking problems for people with early-stage disease. While welcoming the idea of a ‘new era’ for treating Alzheimer’s disease, ...  Show more

Controversial new Alzheimer's drug in the spotlight
Business Daily

After decades without progress, this June a new treatment was approved by the US Food and Drugs Administration - Biogen's Aduhelm. Ivana Davidovic looks into why this process has been so controversial that is now under investigation by a federal watchdog.Aaron Kesselheim, a Harva ...  Show more

Declining ALS Patients Are Waiting On The FDA's Next Move
Big Take

For many years, pharmaceutical companies have tried and failed to find a treatment to slow symptoms of ALS–the debilitating, fatal illness also known as Lou Gehrig’s Disease. A potentially promising new drug from Biogen may offer some relief to those afflicted with an uncommon an ...  Show more